Company Quick10K Filing
Datawatch
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 13 $152
10-K 2018-12-13 Annual: 2018-09-30
10-Q 2018-07-27 Quarter: 2018-06-30
10-Q 2018-05-10 Quarter: 2018-03-31
10-Q 2018-02-06 Quarter: 2017-12-31
10-K 2017-11-21 Annual: 2017-09-30
10-Q 2017-07-28 Quarter: 2017-06-30
10-Q 2017-04-28 Quarter: 2017-03-31
10-Q 2017-01-27 Quarter: 2016-12-31
10-K 2016-11-10 Annual: 2016-09-30
10-Q 2016-07-25 Quarter: 2016-06-30
10-Q 2016-04-22 Quarter: 2016-03-31
10-Q 2016-01-29 Quarter: 2015-12-31
10-K 2015-11-13 Annual: 2015-09-30
10-Q 2015-07-29 Quarter: 2015-06-30
10-Q 2015-05-08 Quarter: 2015-03-31
10-Q 2015-02-09 Quarter: 2014-12-31
10-K 2014-12-05 Annual: 2014-09-30
10-Q 2014-08-01 Quarter: 2014-06-30
10-Q 2014-04-30 Quarter: 2014-03-31
10-Q 2014-02-06 Quarter: 2013-12-31
10-K 2013-12-17 Annual: 2013-09-30
10-Q 2013-08-14 Quarter: 2013-06-30
10-Q 2013-05-13 Quarter: 2013-03-31
10-Q 2013-02-13 Quarter: 2012-12-31
10-K 2012-12-21 Annual: 2012-09-30
10-Q 2012-05-15 Quarter: 2012-03-31
10-Q 2012-02-13 Quarter: 2011-12-31
10-K 2011-12-22 Annual: 2011-09-30
10-Q 2011-08-11 Quarter: 2011-06-30
10-Q 2011-05-11 Quarter: 2011-03-31
10-Q 2011-02-14 Quarter: 2010-12-31
10-K 2010-12-17 Annual: 2010-09-30
10-Q 2010-08-13 Quarter: 2010-06-30
10-Q 2010-05-14 Quarter: 2010-03-31
10-Q 2010-02-16 Quarter: 2009-12-31
8-K 2018-12-13 Leave Agreement, M&A, Shareholder Rights, Control, Officers, Amend Bylaw, Exhibits
8-K 2018-11-15 Earnings, Exhibits
8-K 2018-11-05 Enter Agreement, Other Events, Exhibits
8-K 2018-07-18 Earnings, Exhibits
8-K 2018-07-13 Officers
8-K 2018-04-25 Earnings, Exhibits
8-K 2018-04-17 Shareholder Vote
8-K 2018-01-25 Earnings, Exhibits
8-K 2018-01-24 Enter Agreement, M&A, Off-BS Arrangement, Regulation FD, Exhibits

Datawatch Financials

DWCH Metrics, Comps, Filings

Annual | Quarterly

Business

Consummation of the Merger is subject to various conditions set forth in the Merger Agreement, including, but not limited to the receipt of required approvals, waivers and consents, and other conditions set forth in Annex I to the Merger Agreement. The Merger is not subject to any financing condition.

Datawatch Corporation (NASDAQ-CM: DWCH) (“Datawatch”, “We”, “Us”, “Our”) is a leading provider of self-service data preparation and visual data discovery software. Datawatch began offering self-service data preparation solutions more than 25 years ago to help companies unlock data from multiple sources so that it can be used for analytic tasks. Since then, the sources and variety of data - as well as its volume - have grown significantly and are predicted to continue to grow, posing greater challenges for businesses that depend on accessing data to derive business insights. Today, Datawatch focuses on delivering software that enables users to uncover valuable insights that improve both business outcomes and user productivity. With Datawatch software, businesses can quickly access, prepare and blend structured data from relational databases, enterprise applications, big data systems, etc. along with semi-structured sources like XML, HTML, enterprise reports, PDF files and EDI streams. Additionally, real-time streaming data can be leveraged into visually rich analytic applications to dynamically discover key factors that impact their business operations. Organizations of many sizes and in many different industries use Datawatch products, including 99 of the Fortune 100. Datawatch is headquartered in Bedford, Massachusetts, with offices in New York, Toronto, London, Stockholm, Singapore, and Manila, and with partners and customers in more than 100 countries worldwide.

Datawatch is a Delaware corporation, formed in 1986, with executive offices located at 4 Crosby Drive, Bedford, MA 01730 and our telephone number is (978) 441-2200. Periodic reports, proxy statements and other information are available to the public, free of charge, on our website, www.datawatch.com, as soon as reasonably practicable after they have been filed with the SEC and through the SEC's website, www.sec.gov. Such reports, proxy statements and other information may be obtained by visiting the Public Reference Room of the SEC at 100 F Street, N.E., Washington, DC 20549 or by calling the SEC at 1-800-SEC-0330.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Jamba (JMBA) 165,009 0% 68.1 -4% 36,654 46,912 78,265 0 -1,563 2,289 155,914
QNB (QNBC) 161,973 5.8 1% 1,212,005 1,096,127 0 0 12,060 25,667 147,905
Diverse Development Group (DDG) 161,311 -2,021.4 -401,195% 0 163 0 0 -80 -80 161,311
Gold Reserve (GDRZF) 161,165 -8.9 -15% 78,340 104,144 0 0 -11,575 -11,575 103,488
SolarWindow Technologies (WNDW) 158,348 -31.5 -25% 19,230 260 0 0 -4,722 -4,462 140,358
Blackstar Enterprise Group (BEGI) 156,000 -212.5 -2,503% 29 276 0 0 -734 -734 155,980
Invesco CurrencyShares Swiss Franc Trust (FXF) 155,749 -12.9 -1% 147,556 146 0 0 -1,838 -634 8,194
Invesco DB Gold Fund (DGL) 155,016 13.6 7% 155,325 92 0 0 11,418 11,431 155,016
Northwest Indiana Bancorp (NWIN) 153,612 5.4 1% 1,309,349 1,180,537 0 0 11,107 20,386 110,521
Datawatch (DWCH) 151,567 0% -21.0 -15% 61,684 35,167 42,197 0 -9,252 -6,958 146,374
MJ Holdings (MJNE) 146,709 -59.6 -41% 5,986 746 0 0 -2,440 -2,440 145,294
Nutriband (NTRB) 146,447 -9% -74.9 -86% 2,353 720 514 -48 -2,028 -1,954 146,433
Northwest Biotherapeutics (NWBO) 146,250 0% -18.5 -94% 14,704 67,711 922 0 -13,799 -8,434 155,730
First Keystone (FKYS) 146,194 8.2 1% 1,003,812 878,105 0 0 9,731 22,259 182,362
Alliance One (AOI) 146,055 14% 7.1 -7% 1,965,575 1,835,010 1,787,275 249,131 -131,412 122,929 878,400
Kentucky Bancshares (KTYB) 143,552 5.0 1% 1,083,497 967,350 0 0 12,262 22,992 115,661
Applied Therapeutics (APLT) 141,874 -5.9 -37% 46,784 6,780 0 0 -17,167 -17,167 100,798
Trevi Therapeutics (TRVI) 141,428 -5.8 -16% 75,116 7,413 0 0 -12,148 -12,157 70,041
First Northern Community Bancorp (FNRN) 141,029 0.8 1% 1,232,218 1,107,336 0 0 14,206 21,110 16,744
Windtree Therapeutics (WINT) 138,735 0% -7.4 -18% 105,245 46,975 1,478 0 -19,022 -17,955 132,458

Balance Sheet ($'000)2011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-30
Cash8,3848,72210,31247,66835,16228,03430,45113,735
Accounts Receivable2,9664,3916,6227,0247,0816,9327,3069,802
Inventory495945148
PP&E2702812,4252,5596141,2101,0641,047
Assets13,13422,80569,321103,59758,93148,43150,40561,684
Accounts Payable8796761,4339251,5461,7582,3602,074
Long-Term Debt2,9832,1086,440
Liabilities6,79213,11117,94612,68713,38914,47317,87635,167
Stockholders' Equity6,3429,69451,37590,91045,54233,95832,52926,517
Income Statement ($'000)2011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-30
Revenue17,88526,00630,29635,08730,22130,46236,26341,678
Cost of Revenue
Gross Profit
R&D
SG&A10,54216,87325,27540,31435,63630,41927,90134,432
Tax355038122393418-11
Net Income1321,034-4,197-22,383-49,787-14,632-3,993-9,252
Cash Flow ($'000)2011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-30
Cash Operating1,1473,9562,394-10,992-11,931-6,2692,292-558
Cash Investing-76-8,819-525-526-490-966-277-24,729
Cash Financing3885,0896348,965521054228,814